Effects of 12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep and Psychological Wellbeing - a Randomised, Placebo-controlled Trial

What this Trial Is About

Perimenopause is the phase before menopause where women experience symptoms like hot flushes, night sweats, mood swings, anxiety, sleep problems, fatigue, and trouble with memory or concentration. These symptoms can be frequent and intense, affecting quality of life. Despite growing awareness, there is limited research on how diet and supplements impact menopause symptoms. This study investigates the effects of 12 weeks of magnesium supplementation on symptoms, cognition, sleep, and psychological well-being in perimenopausal women. The study compares two groups one taking a magnesium hydroxide supplement and the other a placebo, both for 12 weeks. Each participant will take two capsules daily of either magnesium hydroxide or placebo. The trial is randomized and triple-blinded to fairly assess the effects of magnesium. The treatment period lasts 84 days with assessments conducted at baseline, 6 weeks, and 12 weeks. Participants will complete memory and cognitive tasks, such as numeric and alphabetic working memory tests, recognition tasks, and the Corsi blocks task, at three time points. They will also fill out questionnaires measuring menopause-specific quality of life, depression, anxiety, stress, mood, and sleep quality. These measures will help researchers understand how magnesium may influence cognition, psychological health, and sleep during perimenopause. The study is led by Northumbria University and plans to end in August 2026.

12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being